Znn3bq.jpeg
ÉÇÍ·´óѧº£Ñó¿ÆÑ§½ÓÊܵ÷¼Á
²é¿´: 4272  |  »Ø¸´: 116
¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û105´Î£¬×÷Õßstar_zhangÔö¼Ó½ð±Ò 84.2 ¸ö
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

star_zhang

½û³æ (ÎÄѧ̩¶·)


[×ÊÔ´] ¡¾Ó¢ÃÀ¾­µäÊé¼®¡¿¡¶ÁÙ´²Ò©ÎïÊÔÑéºÍÄ¥ÄÑ¡·(µÚ2°æ)¡¾ÒÑËÑË÷£¬ÎÞÖØ¸´¡¿

¡¾Ó¢ÃÀ¾­µäÊé¼®¡¿¡¶Clinical Drug Trials and Tribulations¡·(µÚ2°æ)¡¾ÒÑËÑË÷£¬ÎÞÖØ¸´¡¿

¡¾ÒÑËÑË÷£¬ÎÞÖØ¸´¡¿ÂÛ̳ÀÓÐ1¸öͬÃûµÄÌû×Ó£¬Á¬½ÓÒѾ­Ê§Ð§ÁË¡£"µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£"
ʧЧÌû×ÓµÄÁ´½ÓµØÖ·£ºhttp://muchong.com/bbs/viewthread.php?tid=308965&fpage=1&target=blank
Ϊ´Ë£¬ÎÒÖØÐÂÉÏ´«´ËÊ飬¹©ÅóÓÑÃÇѧϰºÍ²Î¿¼¡£


ÎÒÉÏ´«µÄÕâ±¾Ê飺
×÷ÕߣºAllen Cato,Lynda Sutton and Allen Cato III
2002Ä꣬453 Ò³£¬PDF ¸ñʽ£¬2.4 MB¡£
Language: English

.
·âÃæ£º
¡£
¡¾Ó¢ÃÀ¾­µäÊé¼®¡¿¡¶ÁÙ´²Ò©ÎïÊÔÑéºÍÄ¥ÄÑ¡·(µÚ2°æ)¡¾ÒÑËÑË÷£¬ÎÞÖØ¸´¡¿
¡£
¼ò½é£º
Aimed at those already involved in drug development or those considering entering the field, Clinical Drug Trials and Tribulations, Second Edition comprehensibly addresses the new, day-to-day challenges of drug development with valuable assessments of the areas affecting the conduction of nonclinical and clinical studies.

Addressing which decisions should be made during drug development, this updated and expanded text/reference carefully guides readers through the various trials and tribulations that emerge phase-by-phase and are pertinent to all levels of pharmaceutical or clinical drug management.

Bringing together the latest information on drug development, the Second Edition contains:

new material on¡­
international regulation and deregulation
venture capitalist investment
the IND process
informed consent
changes in manufacturing
and updated and extended coverage of¡­
pediatric drug trial design
the advantages and disadvantages of orphan drug designations
the maximization of package inserts for marketing
post approval safety surveillance
withdrawals from the drug market
Clinical Drug Trials and Tribulations, Second Edition will prove an invaluable reference for pharmacologists, pharmacists, clinical chemists, clinical coordinators, clinical monitors, government drug regulatory personnel, and bioethicists as well as a useful text for medical or pharmacy school courses on pharmaceutical development and research.
==============================

¾´Çë¸÷λÅóÓÑ£¬ÏÂÔØÖ®ºó£¬¸ø¸ö»ØÌûÆÀ¼Û¡£ÎÒÒ²ºÃ¼ÌÐøÍÆ³öÏÂÒ»¸ö×îпƼ¼Êé¼®¡£
(²»ÏÂÔØ£¬Ò²¿ÉÒÔÆÀ¼Û¡£)
лл£¡
»Ø¸´´ËÂ¥

» ±¾Ìû¸½¼þ×ÊÔ´Áбí

  • »¶Ó­¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
    ±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com
  • ¸½¼þ 1 : Clinical_drug_trials_and_tribulations_2nd_edition_2002.pdf
  • 2014-11-02 05:49:48, 2.39 M

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

ѧϰ×ÊÁÏ£¨Àí¹¤Àࣩ Ò©ÎïÉ걨Ó빤ÒÕÉè¼Æ Ò©ÎïÑз¢ÖªÊ¶ ÍõÊϺϳÉ×ÊÔ´Óë½»Á÷
ҽҩͼÊé ´ýÏÂÔØ Ò½orÒ© ÐÂÒ©Ñз¢»ù´¡
´ýÏÂÔØ Ò©¼ÁѧʵÓÃר¼­

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

1949stone

ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

ÁÙ´²Ò©ÎïÊÔÑéºÍÄ¥ÄÑ
19Â¥2014-11-03 13:01:05
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 117 ¸ö»Ø´ð
¼òµ¥»Ø¸´
2014-11-02 10:19   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
2014-11-02 11:47   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
work0375Â¥
2014-11-02 12:41   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
2014-11-02 16:47   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
2014-11-02 21:10   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
Temin20098Â¥
2014-11-02 21:29   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
sjshvdc9Â¥
2014-11-02 21:59   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
lindoudou10Â¥
2014-11-02 22:14   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
zengx611Â¥
2014-11-02 22:24   »Ø¸´  
ÈýÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
i16812Â¥
2014-11-02 23:04   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
195806721113Â¥
2014-11-02 23:04   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
muohio89614Â¥
2014-11-02 23:51   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 297¹¤¿Æµ÷¼Á? +12 ºÓÄÏũҵ´óѧ-ÄÜ 2026-04-13 12/600 2026-04-14 11:05 by ganguoaichi
[¿¼ÑÐ] 26ҩѧר˶105500Çóµ÷¼Á +5 à¶¹þ¼ÓÓÍ 2026-04-13 5/250 2026-04-14 10:15 by Çóµ÷¼Ázz
[¿¼ÑÐ] Ò»Ö¾Ô¸¹þ¹¤´ó 085600 277 12²Ä¿Æ»ùÇóµ÷¼Á 5+5 chenny174 2026-04-10 37/1850 2026-04-14 07:39 by Abskk
[¿¼ÑÐ] Ò»Ö¾Ô¸2110£¬»¯Ñ§Ñ§Ë¶310·Ö£¬±¾¿ÆÖصãË«·ÇÇóµ÷¼Á +20 ŬÁ¦·Ü¶·112 2026-04-08 20/1000 2026-04-13 14:24 by ÕÅzhihao
[¿¼ÑÐ] ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©×ö¹ý·Ö×ÓʵÑé +9 ÏàÐűػá¹ââÍòÕ 2026-04-07 10/500 2026-04-13 10:20 by ¿Éµ­²»¿ÉÍü
[¿¼ÑÐ] ÉúÎïѧµ÷¼Á£¬Ò»Ö¾Ô¸Î÷ÄÏ´óѧ348£¬TopÆÚ¿¯Ò»Çø¶þ×÷¡¢¶þÇøÈý×÷£¬ÈýµÈ½±Ñ§½ðÈý´Î +5 candyyyi 2026-04-09 5/250 2026-04-13 09:02 by ¿Éµ­²»¿ÉÍü
[¿¼ÑÐ] 0831Ò»ÂÖµ÷¼Áʧ°ÜÇóÖú +10 СÐÜî£î£_s 2026-04-11 10/500 2026-04-12 22:43 by ³¤¹­°Á
[½Ìʦ֮¼Ò] ɽ¶«Ë«·ÇԺУ¿¼ºË³¬¼¶ÎÞµ×Ïߣ¬Áìµ¼ÐÒÔÖÀÖ»ö£¬½ÌʦÔâÑê¿Ö +3 qut2026 2026-04-11 7/350 2026-04-12 20:24 by qut2026
[¿¼ÑÐ] 0831ÉúÒ½¹¤µÚÒ»ÂÖµ÷¼Áʧ°ÜÇóÖú +12 СÐÜî£î£_s 2026-04-11 16/800 2026-04-12 16:28 by îÚè±
[¿¼ÑÐ] 359Çóµ÷¼Á +5 θ¾·ÂÎÀÛÁË 2026-04-11 5/250 2026-04-11 19:55 by lbsjt
[¿¼ÑÐ] 269Çóµ÷¼Á +11 °¡°¡ÎÒÎÒ 2026-04-07 11/550 2026-04-11 16:45 by vgtyfty
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸´óÁ¬Àí¹¤´óѧ354·Ö +5 ÓêÉùÓàÉú 2026-04-11 6/300 2026-04-11 16:12 by ÓêÉùÓàÉú
[¿¼ÑÐ] 284Çóµ÷¼Á +12 archer.. 2026-04-10 13/650 2026-04-11 08:44 by zhq0425
[¿¼ÑÐ] 309Çóµ÷¼Á +14 wdhw 2026-04-10 15/750 2026-04-10 21:06 by zhouxiaoyu
[¿¼ÑÐ] ¼ÆËã»úÀàÇóµ÷¼Á£¬22408-274·Ö +7 Éϰ¶deС³æ 2026-04-09 8/400 2026-04-10 19:56 by fxue1114
[¿¼ÑÐ] 293µ÷¼Á +25 yj1221 2026-04-08 26/1300 2026-04-10 15:02 by ²ñС°×
[¿¼ÑÐ] ²ÄÁÏר˶(0856) 339·ÖÇóµ÷¼Á +9 ¹þ¹þ¹þ¶ì¹þ¹þ¹þ 2026-04-09 10/500 2026-04-09 20:01 by Orcid
[¿¼ÑÐ] ²ÄÁÏר˶³õÊÔ·Ö332Ò»Ö¾Ô¸Î÷±±¹¤Òµ´óѧ£¬ +12 ¹ÊÈË?? 2026-04-09 12/600 2026-04-09 18:34 by Ccclqqq
[¿¼ÑÐ] 337Çóµ÷¼Á +4 Gky09300550£¬ 2026-04-09 4/200 2026-04-09 17:18 by ÅÁ¶ûÂíÀ­ÌØ
[¿¼ÑÐ] Çóµ÷¼Á£¬ÏÖÔÚ»¹ÄÜÌîµÄ +3 Éϰ¶Ð¡Ó¨¼ÓÓÍ 2026-04-08 3/150 2026-04-08 14:30 by zhq0425
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û